Gut Microbiota In Cardiologic Patients: Aggressive Or Defensive Factor?

Abstract

Gut microbiota (GM) is a peculiar marker of the macroorganism status, capable of responding to the age, physiological, dietary, climatic and geographical factors by changing the qualitative and quantitative compositions. The last decade is characterized by a significant reassessment of the involvement of gut microbiota into the progression of chronic human diseases. This article presents an overview of recent experimental and clinical data on the role of gut microbiota in the development of atherosclerosis and cardiovascular diseases. An attempt has been made to analyze the mutual modifying effects of GM and the main types of drugs used in cardiology, as well as the limitations and directions of future research in this field.